Vertex Pharmaceuticals Inc (VRTX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$138.69B
EV to revenue ratio (TTM)
10.74
EV to ebitda
27.59
Financial Performance
Revenue (TTM)
$12.95B
Gross profit (TTM)
$7.10B
EBITDA
$5.10B
Profitability
Operating margin (TTM)
37.80%
Profit margin
30.70%
Return on assets (TTM)
10.60%
Return on equity (TTM)
20.80%
Per Share Metrics
Revenue per share (TTM)
$51.06
EPS
$15.54
Diluted EPS (TTM)
$15.54
Book value
$82.47
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
35.20
Trailing P/E
35.20
Forward P/E
26.60
PEG ratio
2.38
Price to sales ratio (TTM)
10.71
Price to book ratio (TTM)
6.64
Growth
Quarterly earnings growth (YoY)
11.80%
Quarterly revenue growth (YoY)
-39.00%
Analyst Sentiment
Strong buy
6
Buy
20
Hold
4
Sell
1
Strong sell
1
Risk & Volatility
Beta
0.28